Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 46792
95 % 2 2 42686 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 40627
70 % 2 2 35939
50 % 2 2 31152
40 % 22 33 1393
30 % 27 40 1193
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 72328
95 % 1 1 44710
90 % 465 798 2
70 % 1532 2439 2
50 % 3888 6281 1
40 % 3888 6281 1
30 % 3916 6327 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 72327
95 % 1 1 59682
90 % 1 1 56231
70 % 1861 3009 1
50 % 3889 6281 1
40 % 3889 6281 1
30 % 3917 6327 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 72330
95 % 2 2 35967 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 34381
70 % 1862 3009 1
50 % 3890 6281 1
40 % 3890 6281 1
30 % 3918 6327 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 58458
95 % 134 235 67 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 466 798 2
70 % 1533 2439 2
50 % 3891 6281 1
40 % 3891 6281 1
30 % 3919 6327 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
29 6MEE 2 B, D antibody HEPC74 Light Chain 9606
30 6BJZ 1 H 5c8 Fab Heavy chain 9606
31 6BJZ 2 L 5c8 Fab Light chain 9606
32 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
33 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
34 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
35 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
36 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
37 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
38 4XCF 1 L 4E10 Fab light chain 9606
39 4XCF 2 H 4E10 Fab heavy chain 9606
40 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
41 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
42 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
43 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
44 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
45 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
46 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
47 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
48 5X08 1 H Fab 4E10 Heavy chain 9606
49 5X08 2 L Fab 4E10 Light chain 9606
50 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
51 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
52 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
53 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
54 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
55 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
56 6MEG 1 H antibody HEPC46 Heavy Chain 9606
57 6MEG 2 L antibody HEPC46 Light Chain 9606
58 5C2B 1 H scFv 3B4 9606
59 6O3K 1 L PGZL1.H4K3 light chain 9606
60 6O3K 2 H PGZL1.H4K3 heavy chain 9606
61 4XAW 1 L 4E10 Fab light chain 9606
62 4XAW 2 H 4E10 Fab heavy chain 9606
63 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
64 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
65 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
66 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
67 5UCB 1 H Fab Heavy Chain 9606
68 5UCB 2 L Fab Light Chain 9606
69 2VXV 1 H HUMAN IGG ABT-325 9606
70 2VXV 2 L HUMAN IGG ABT-325 9606
71 6QF9 1 A, B scFv 9606
72 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
73 4GXV 1 H, I Antibody 1F1, heavy chain 9606
74 4GXV 2 L, M Antibody 1F1, light chain 9606
75 2VXT 1 H MURINE IGG 125-2H 10090
76 2VXT 3 L MURINE IGG 125-2H 10090
77 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
78 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
79 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
80 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
81 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
82 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
83 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
84 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
85 5W24 1 L 5C4 Fab Light Chain 10090
86 5W24 2 H 5C4 Fab Heavy Chain 10090
87 4HPY 1 H CH59 Fab heavy chain 9606
88 4HPY 2 L CH59 Fab light chain 9606
89 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
90 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
91 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
92 4JG1 1 L Fab light chain 9606
93 4JG1 2 H Fab heavy chain 9606
94 6E65 1 L TB31F Fab light chain 9606
95 6E65 2 H TB31F Fab heavy chain 9606
96 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
97 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
98 5VF2 1 A scFv 2D10 10090
99 5I8C 1 A VRC34.01 Fab heavy chain 9606
100 5I8C 2 B VRC34.01 Fab light chain 9606
101 4O5L 1 L Fab F045-092 light chain 9606
102 4O5L 2 H Fab F045-092 heavy chain 9606
103 5MYX 1 A, C Fab c#24 light chain 10090
104 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
105 3IFL 1 L 12A11 FAB antibody light chain 10090
106 3IFL 2 H 12A11 FAB antibody heavy chain 10090
107 5WK2 1 L M116 LIGHT CHAIN 9606
108 5WK2 2 H M116 HEAVY CHAIN FD 9606
109 3PP4 1 H GA101 Fab heavy chain 10090
110 3PP4 2 L GA101 Fab light chain 10090
111 3KDM 1 A, L Immunoglobulin light chain 9606
112 3KDM 2 B, H Immunoglobulin heavy chain 9606
113 5NIV 1 A Light chain of 5D3 Fab 10090
114 5NIV 2 B Heavy chain of 5D3 Fab 10090
115 6UG7 1 L ch28/11 Fab light chain 10090
116 6UG7 2 H ch28/11 Fab heavy chain 10090
117 5N4J 1 L LIGHT CHAIN 9606
118 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
119 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
120 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
121 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
122 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
123 5X4G 1 A 6H8 Fab heavy chain 10090
124 5X4G 2 B 6H8 Fab light chain 10090
125 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
126 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
127 4PTU 1 A Antibody pn132p2C05, light chain 9606
128 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
129 4TPR 1 L If kappa light chain 10090
130 4TPR 2 H Fab heavy chain 10090
131 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
132 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
133 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
134 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
135 3IFN 1 H 12A11 FAB antibody heavy chain 10090
136 3IFN 2 L 12A11 FAB antibody light chain 10090
137 5U3P 1 H DH511.4 Fab Heavy Chain 9606
138 5U3P 2 L DH511.4 Fab Light Chain 9606
139 6BLA 1 H AMM01 Fab Heavy chain 9606
140 6BLA 2 L AMM01 Fab Light chain 9606
141 4TOY 1 H 35O22 Fab Heavy chain 9606
142 4TOY 2 L 35O22 Fab Light chain 9606
143 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
144 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
145 3NPS 2 B S4 FAB HEAVY CHAIN 9606
146 3NPS 3 C S4 FAB LIGHT CHAIN 9606
147 5I4F 1 A scFv 2D10 10090
148 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
149 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
150 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
151 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
152 5WN9 1 H scFv 2D10 9606
153 4XC3 1 L 4E10 Fab light chain 9606
154 4XC3 2 H 4E10 Fab heavy chain 9606
155 4M5Y 1 H, I Fab 5J8 heavy chain 9606
156 4M5Y 2 L, M Fab 5J8 light chain 9606
157 4TQE 1 L If kappa light chain 10090
158 4TQE 2 H Fab heavy chain 10090
159 5YY4 1 A scFv 4B08 10090
160 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
161 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
162 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
163 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
164 6Q19 1 L Fab lambda chain 9606
165 6Q19 2 H Fab heavy chain 9606
166 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
167 5VSI 2 L CH1/Ckappa Fab light chain 9606
168 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
169 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
170 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
171 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
172 5JXA 1 H VRC03 Heavy chain 9606
173 5JXA 2 L VRC03 Light chain 9606
174 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
175 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
176 6QCU 1 L Light chain 9606
177 6QCU 2 H Heavy chain 9606
178 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
179 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
180 3NTC 1 L Fab light chain 10090
181 3NTC 2 H Fab heavy chain 10090
182 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
183 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
184 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
185 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
186 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
187 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
188 6PZG 1 L NA-80 Fab light chain 9606
189 6PZG 2 H NA-80 Fab heavy chain 9606
190 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
191 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
192 6BE3 1 H Fab (F598) Heavy Chain 9606
193 6BE3 2 L Fab (F598) Light Chain 9606
194 4NWU 1 H APE1551 Ab Fab heavy chain 9606
195 4NWU 2 L APE1551 Ab Fab light chain 9606
196 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
197 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
198 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
199 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
200 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
201 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
202 5EWI 1 H VRC38.01 Heavy Chain 9606
203 5EWI 2 L VRC38.01 Light Chain 9606
204 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
205 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
206 5E2W 1 L AT8 LIGHT CHAIN 10090
207 5E2W 2 H AT8 HEAVY CHAIN 10090
208 5MYK 1 A Fab c#17 light chain 10090
209 5MYK 2 B Fab c#17 heavy chain 10090
210 4NZR 1 H PGT135 heavy chain Fab 9606
211 4NZR 2 L PGT135 light chain Fab 9606
212 5MYO 1 A, C Fab c#6 light chain 10090
213 5MYO 2 B, D Fab c#6 heavy chain 10090
214 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
215 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
216 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
217 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
218 5UEL 1 H 354NC102 Fab Heavy Chain 9606
219 5UEL 2 L 354NC102 Fab Light Chain 9606
220 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
221 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
222 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
223 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
224 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
225 5E2V 1 L AT8 LIGHT CHAIN 10090
226 5E2V 2 H AT8 HEAVY CHAIN 10090
227 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
228 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
229 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
230 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
231 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
232 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
233 5JUE 1 L light chain of UIC2 Fab 10090
234 5JUE 2 H heavy chain of UIC2 Fab 10090
235 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
236 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
237 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
238 5JR1 1 H 10E8 heavy chain 9606
239 5JR1 2 L 10E8 mature light chain 9606
240 6CA7 1 L PCT64_13C light chain 9606
241 6CA7 2 H PCT64_13C heavy chain 9606
242 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
243 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
244 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
245 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
246 6MVL 2 H Antibody Fab fragment heavy chain 9606
247 6MVL 3 L Antibody Fab fragment light chain 9606
248 5OB5 2 H fAb Heavy chain 9606
249 5OB5 3 L fAb Light chain 9606
250 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
251 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
252 5I66 1 A 8B6 antibody, heavy chain 10090
253 5I66 2 B 8B6 antibody, light chain 10090
254 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
255 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
256 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
257 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
258 6BZY 1 H 22D11 Heavy Chain 10090
259 6BZY 2 L 22D11 Light Chain 10090
260 3QQ9 1 C, L 101F LIGHT CHAIN 10090
261 3QQ9 2 D, H 101F HEAVY CHAIN 10090
262 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
263 5TKK 3 L mouse antibody vFP5.01 light chain 10090
264 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
265 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
266 5W6C 1 H UCA Fab heavy chain 9606
267 5W6C 2 L UCA Fab light chain 9606
268 5I1K 1 L FAB LIGHT CHAIN 9606
269 5I1K 2 H FAB HEAVY CHAIN 9606
270 3OZ9 1 L Fab NC-1 kappa light chain 10090
271 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
272 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
273 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
274 5V7U 1 L CBTAU-22.1 Fab light chain 9606
275 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
276 5UEA 1 A, H Fab Heavy Chain 9606
277 5UEA 3 B, L Fab Light Chain 9606
278 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
279 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
280 3G5Y 1 A 175 light chain 10090
281 3G5Y 2 B 175 heavy chain 10090
282 5NMV 1 L Fab light chain 10088
283 5NMV 2 H Fab heavy chain 10088
284 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
285 4N8C 2 L, M Light chain of monoclonal antibody 10090
286 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
287 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
288 4HGW 1 A Antibody Fab fragment, light chain 10090
289 4HGW 2 B Antibody Fab fragment, heavy chain 10090
290 1NLB 1 L antibody 19D9D6 light chain 10090
291 1NLB 2 H antibody 19D9D6 heavy chain 10090
292 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
293 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
294 3VFG 1 L 3F8 Light Chain 10090
295 3VFG 2 H 3F8 Heavy Chain 10090
296 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
297 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
298 3QRG 1 L Fab light chain 9606
299 3QRG 2 H Fab heavy chain Fd fragment 9606
300 5M6A 1 A, B, C, D Bence-Jones light chain 9606
301 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
302 4LLY 2 B, D light chain Clambda 9606
303 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
304 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
305 5EZI 1 H Fab c12 heavy chain 9606
306 5EZI 2 L Fab c12 Light chain 9606
307 4K23 1 H anti-uPAR antibody, heavy chain 10090
308 4K23 2 L anti-uPAR antibody, light chain 10090
309 3NCJ 1 L Fab15 Mut8 light chain 9606
310 3NCJ 2 H Fab15 Mut8 heavy chain 9606
311 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
312 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
313 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
314 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
315 5W05 1 L M59 FAB LIGHT CHAIN 10090
316 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
317 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
318 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
319 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
320 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
321 4M61 1 A, C Fab A52 light chain 10090
322 4M61 2 B, D Fab A52 heavy chain 10090
323 5YE3 1 B 2A7D9 VH CH1 chain 10090
324 5YE3 2 A 2A7D9 L chain 10090
325 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
326 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
327 1UM5 1 L Antibody 21H3 L chain 10090
328 1UM5 2 H Antibody 21H3 H chain 10090
329 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
330 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
331 4NWT 1 L APE1531 Ab Fab light chain 9606
332 4NWT 2 H APE1531 Ab Fab heavy chain 9606
333 3WHX 1 A mAb Fab H fragment 10090
334 3WHX 2 B mAb Fab L fragment 10090
335 3NA9 1 L Fab15 light chain 9606
336 3NA9 2 H Fab15 heavy chain 9606
337 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
338 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
339 6RCO 1 A, C R5.004 heavy chain 9606
340 6RCO 2 B, D R5.004 light chain 9606
341 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
342 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
343 4LRI 1 A, B MSL-109 Light Chain 9606
344 4LRI 2 C, P MSL-109 Heavy Chain 9606
345 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
346 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
347 4JN2 1 A, L anti dabigatran Fab 10090
348 4JN2 2 B, H anti dabigatran Fab 10090
349 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
350 4XBE 2 H 4E10 Fab heavy chain 9606
351 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
352 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
353 6BE2 1 H Fab (F598) Heavy Chain 9606
354 6BE2 2 L Fab (F598) Light Chain 9606
355 4JFZ 1 L Fab light chain 9606
356 4JFZ 2 H Fab heavy chain 9606
357 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
358 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
359 3WIF 1 A mAb Fab H fragment 10090
360 3WIF 2 B mAb Fab L fragment 10090
361 5U6A 1 A Light Chain 9606
362 5U6A 2 B Heavy Chain 9606
363 6K0Y 1 A Antibody Heavy Chain 9606
364 6K0Y 2 B Antibody Light Chain 9606
365 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
366 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
367 3MBX 1 L X836 LIGHT CHAIN 10090
368 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
369 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
370 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
371 6APC 1 H Epididymis luminal protein 214 9606
372 6APC 2 L IGL@ protein 9606
373 4HHA 1 A Fab KE5 Fab fragment KE5 9606
374 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
375 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
376 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
377 4RGO 2 H 14G8 heavy chain Fab 10090
378 4RGO 3 L 14G8 light chain Fab 10090
379 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
380 5GRY 1 A, G diabody 9606
381 5UEK 2 H Fab 12E Heavy Chain 9606
382 5UEK 3 L Fab 12E Light Chain 9606
383 3NAA 1 L Fab15 Mut5 light chain 9606
384 3NAA 2 H Fab15 Mut5 heavy chain 9606
385 1Q0X 1 L Fab 9B1, light chain 10090
386 1Q0X 2 H Fab 9B1, heavy chain 10090
387 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
388 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
389 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
390 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
391 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
392 5IK3 2 B, D 1E03 Fab fragment light chain 9606
393 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
394 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
395 5XLI 1 a, b FabL 10090
396 5XLI 2 c, d FabH 10090
397 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
398 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
399 6DC4 1 H Fab AM22 Heavy Chain 9606
400 6DC4 2 L Fab AM22 Light Chain 9606
401 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
402 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
403 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
404 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
405 4WUK 1 H CH65 heavy chain 9606
406 4WUK 2 L CH65 light chain 9606
407 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
408 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
409 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
410 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
411 5JOP 1 D, L Fab 14.22 light chain 10090
412 5JOP 2 E, H Fab14.22 heavy chain 10090
413 4HPO 1 H CH58 Fab heavy chain 9606
414 4HPO 2 L CH58 Fab light chain 9606
415 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
416 5UKN 2 L DH522UCA Fab fragment light chain 9544
417 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
418 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
419 5IT2 1 H heavy chain 9606
420 5IT2 2 L light chain 9606
421 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
422 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
423 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
424 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
425 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
426 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
427 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
428 5MO3 3 L Fab of monoclonal antibody, light chain 10090
429 5GZ0 1 A, C FM329 light chain 1383439
430 5GZ0 2 B, D FM329 heavy chain 1383439
431 6DW2 1 A 6078 Fab light chain 9606
432 6DW2 2 B 6078 Fab heavy chain 9606
433 6MG4 1 A, B JTO light chain 9606
434 6BQB 1 L MGG4 Fab light chain 9606
435 6BQB 2 H MGG4 Fab heavy chain 9606
436 4PUB 1 H DX-2930 HEAVY CHAIN 9606
437 4PUB 2 L DX-2930 LIGHT CHAIN 9606
438 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
439 6B14 2 L Light chain of Fab BL3-6S97N 10090
440 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
441 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
442 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
443 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
444 5GS3 1 A, H diabody protein 9606
445 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
446 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
447 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
448 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
449 5VKD 2 H Fab Heavy Chain 9606
450 5VKD 3 L Fab light chain 9606
451 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
452 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
453 5XHG 1 A, C polypeptide(L) 10090
454 5XHG 2 B, D polypeptide(H) 10090
455 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
456 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
457 3UYR 1 H antibody Fab heavy chain 10090
458 3UYR 2 L antibody Fab light chain 10090
459 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
460 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
461 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
462 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
463 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
464 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
465 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
466 3OAZ 2 K, L Fab 2G12, light chain 9606
467 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
468 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
469 1ZAN 1 L Fab AD11 Light Chain 10116
470 1ZAN 2 H Fab AD11 Heavy Chain 10116
471 6CJK 1 A, C Immunoglobulin Fab light chain 9986
472 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
473 4N0Y 1 H IGH526 Heavy Chain 9606
474 4N0Y 2 L IGH526 Light Chain 9606
475 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
476 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
477 6OTC 2 H sFab H3 heavy chain 32630
478 6OTC 3 L sFab H3 light chain 32630
479 6Q1G 1 L H1244 Fab lambda chain 9606
480 6Q1G 2 H H1244 Fab heavy chain 9606
481 5MTH 1 A, H antibody Fab heavy chain 10090
482 5MTH 2 B, L antibody Fab light chain 10090
483 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
484 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
485 1RZF 1 L Fab E51 light chain 9606
486 1RZF 2 H Fab E51 heavy chain 9606
487 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
488 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
489 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
490 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
491 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
492 4KTE 2 L GE148 Light Chain Fab 9544
493 5I8O 1 H HMM5 antibody heavy chain 9606
494 5I8O 2 L HMM5 antibody light chain 9606
495 4JG0 1 L Fab light chain 9606
496 4JG0 2 H Fab heavy chain 9606
497 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
498 4YGV 2 B, L aDabi-Fab2a light chain 9606
499 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
500 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
501 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
502 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
503 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
504 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
505 3EO0 1 A, C GC-1008 Fab Light Chain 10090
506 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
507 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
508 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
509 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
510 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
511 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
512 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
513 4FQI 3 H antibody CR9114 heavy chain Fab 9606
514 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
515 6S5A 2 H anti P329G LALA Fab heavy chain 10090
516 6S5A 3 L anti P329G LALA Fab light chain 10090
517 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
518 4JHA 2 L D25 light chain 9606
519 6B9Z 1 A Trastuzumab Fab light chain 10090
520 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
521 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
522 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
523 4PTT 1 A Antibody pn132p2C05, light chain 9606
524 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
525 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
526 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
527 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
528 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
529 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
530 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
531 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
532 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
533 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
534 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
535 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
536 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
537 4DGV 1 H HCV1 Heavy Chain Fab 9606
538 4DGV 2 L HCV1 Light Chain 9606
539 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
540 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
541 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
542 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
543 5TH2 1 A, C cetuximab Fab, light chain 10090
544 5TH2 2 B, D cetuximab Fab, heavy chain 10090
545 5I8K 1 L HHH1 Fab Light chain 9606
546 5I8K 2 H HHH1 Fab Heavy chain 9606
547 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
548 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
549 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
550 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
551 1YNL 1 L Ig gamma light chain 10090
552 1YNL 2 H Ig gamma heavy chain 10090
553 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
554 5EPM 2 B, F Antibody Fab fragment light chain 10090
555 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
556 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
557 3UMT 1 A scFv heavy chain and light chain 10090
558 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
559 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
560 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
561 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
562 6UC5 1 H Fab397 heavy chain 9606
563 6UC5 2 L Fab397 light chain 9606
564 4NUJ 1 A PGT152 light chain 9606
565 4NUJ 2 B PGT152 heavy chain 9606
566 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
567 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
568 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
569 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
570 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
571 3U2S 2 B, L PG9 light chain 9606
572 6PE7 1 H FAB Heavy Chain 9606
573 6PE7 2 L FAB Light chain 9606
574 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
575 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
576 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
577 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
578 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
579 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
580 4NUG 1 L PGT151 light chain 9606
581 4NUG 2 H PGT151 heavy chain 9606
582 3IU4 1 H chP3 Fab heavy chain 10090
583 3IU4 2 L chP3 Fab light chain 10090
584 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
585 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
586 6DC8 1 L IgG light chain 10090
587 6DC8 2 H IgG heavy chain 10090
588 6NYQ 1 L 1H3 Fab light chain 10090
589 6NYQ 2 H 1H3 Fab heavy chain 10090
590 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
591 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
592 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
593 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
594 6IAS 1 H Fab NKp46-1 heavy chain 32630
595 6IAS 2 L Fab NKp46-1 light chain 32630
596 1P7K 1 A, L antibody light chain FAB 10090
597 1P7K 2 B, H antibody heavy chain FAB 10090
598 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
599 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
600 3RVV 2 C 4C1 - light chain 10090
601 3RVV 3 D 4C1 - heavy chain 10090
602 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
603 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
604 3P0Y 2 H Fab DL11 heavy chain 9606
605 3P0Y 3 L Fab DL11 light chain 9606
606 4NPY 1 A, L germline PGT121 light chain Fab 9606
607 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
608 6ANA 2 H LL2 Fab Heavy Chain 10090
609 6ANA 3 L LL2 Fab Light Chain 10090
610 5IBU 1 B, L 6652 Light Chain 9606
611 5IBU 2 G, H 6652 Heavy Chain 9606
612 5VPL 2 C 4C1 - LIGHT CHAIN 10090
613 5VPL 3 D 4C1 - HEAVY CHAIN 10090
614 6AOD 1 A FXIa Antibody FAB Light Chain 9606
615 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
616 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
617 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
618 2YPV 2 H FAB 12C1 10090
619 2YPV 3 L FAB 12C1 10090
620 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
621 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
622 4JY5 1 L PGT122 light chain Fab 9606
623 4JY5 2 H PGT122 heavy chain Fab 9606
624 6ELE 1 A, H fAB heavy chain 9606
625 6ELE 2 B, L fAB light chain 9606
626 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
627 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
628 6B5R 1 H CIS42 Fab Heavy chain 9606
629 6B5R 2 L CIS42 Fab Light chain 9606
630 3NAC 1 L Fab15 Mut7 light chain 9606
631 3NAC 2 H Fab15 Mut7 heavy chain 9606
632 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
633 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
634 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
635 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
636 1Q72 1 L Fab M82G2, Light chain 10090
637 1Q72 2 H Fab M82G2, Heavy chain 10090
638 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
639 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
640 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
641 6MNQ 3 L Ab DH727.2 light chain 9544
642 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
643 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
644 4YHO 1 H aDabi-Fab3 heavy chain 9606
645 4YHO 2 L aDabi-Fab3 light chain 9606
646 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
647 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
648 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
649 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
650 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
651 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
652 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
653 4DGY 1 H HCV1 Heavy Chain Fab 9606
654 4DGY 2 L HCV1 Light Chain 9606
655 5EN2 1 A GD01 heavy chain 10090
656 5EN2 2 B GD01 light chain 10090
657 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
658 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
659 6P4Y 1 H 4A10 Fab heavy chain 10090
660 6P4Y 2 L 4A10 Fab light chain 10090
661 3MXW 2 L 5E1 light chain 9606
662 3MXW 3 H 5E1 heavy chain 9606
663 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
664 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
665 3EO9 1 L Efalizumab Fab fragment, light chain 9606
666 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
667 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
668 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
669 6N35 1 K, L Fab 2G12 light chain 9606
670 6N35 2 H, M Fab 2G12 heavy chain 9606
671 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
672 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
673 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
674 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
675 5WUV 1 L light chain 9606
676 5WUV 2 H heavy chain 9606
677 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
678 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
679 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
680 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
681 4JM4 1 H PGT 135 Heavy Chain Fab 9606
682 4JM4 2 L PGT 135 Light Chain Fab 9606
683 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
684 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
685 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
686 5YE4 2 B, D 1A9D7 L chain 10090
687 6B0G 1 C 1245 Antibody, Light Chain 9606
688 6B0G 2 D 1245 Antibody, Heavy Chain 9606
689 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
690 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
691 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
692 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
693 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
694 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
695 6D0X 1 A 2140 Antibody, heavy chain 9606
696 6D0X 2 B 1210 Antibody, light chain 9606
697 6BE4 1 H Fab (F598) Heavy Chain 9606
698 6BE4 2 L Fab(F598) Light Chain 9606
699 5TPP 1 L DH270.5 Fab heavy chain 9606
700 5TPP 2 H DH270.5 Fab light chain 9606
701 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
702 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
703 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
704 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
705 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
706 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
707 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
708 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
709 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
710 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
711 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
712 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
713 5TL5 1 L M2177 LIGHT CHAIN 10090
714 5TL5 2 H M2177 HEAVY CHAIN 10090
715 2FX7 1 L Fab 4E10 Light Chain 9606
716 2FX7 2 H Fab 4E10 Heavy Chain 9606
717 6O39 1 A Antibody F2.I Fab, Light chain 9606
718 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
719 5Y9K 1 L belimumab light chain 9606
720 5Y9K 2 H belimumab heavy chain 9606
721 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
722 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
723 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
724 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
725 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
726 6GLW 3 D, L Fab 1D11 - Light chain 9844
727 3WFH 1 A mAb Fab H fragment 10090
728 3WFH 2 B mAb Fab L fragment 10090
729 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
730 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
731 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
732 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
733 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
734 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
735 6GKU 2 H Fab 6F5 - Heavy Chain 9844
736 6GKU 3 L Fab 6F5 - Light chain 9844
737 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
738 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
739 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
740 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
741 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
742 5HI4 3 D, L CAT-2000 FAB light chain 9606
743 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
744 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
745 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
746 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
747 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
748 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
749 3RVW 2 C 4C1 - light chain 10090
750 3RVW 3 D 4C1 - heavy chain 10090
751 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
752 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
753 5XKU 2 B HNIgGA6 light chain 9606
754 5XKU 3 C HNIgGA6 heavy chain 9606
755 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
756 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
757 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
758 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
759 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
760 5HI5 3 D, L CAT-2000 light chain 9606
761 5JO5 1 A, C, E, H 10E8 gHV 9606
762 5JO5 2 B, D, F, L 10E8 gLV 9606
763 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
764 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
765 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
766 5CCK 2 L Antibody 3BC315 Fab light chain 9606
767 6RNN 1 C, L Immunoglobulin light chain 10090
768 6GXX 1 H FAB 1D9 heavy chain 10090
769 6GXX 2 L FAB 1D9 light chain 10090
770 5I76 1 A, C FM318_light_chain 1383439
771 5I76 2 B, D FM318_heavy_cahin 1383439
772 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
773 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
774 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
775 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
776 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
777 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
778 5I18 1 L FAB LIGHT CHAIN 9606
779 5I18 2 H FAB HEAVY CHAIN 9606
780 6QB3 2 X scFv55 9606
781 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
782 4JN1 2 L anti-dabigatran Fab1, light chain 10090
783 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
784 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
785 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
786 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
787 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
788 4G5Z 2 L canakinumab antibody fragment light chain 9606
789 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
790 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
791 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
792 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
793 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
794 2OK0 2 L Fab ED10 light chain 10090
795 2OK0 3 H Fab ED10 heavy chain 10090
796 3SOB 1 L antibody light chain 9606
797 3SOB 3 H antibody heavy chain 9606
798 6UG8 1 L ch28/11 Fab light chain 10090
799 6UG8 2 H ch28/11 Fab heavy chain 10090
800 6B5M 1 H CIS43 Fab Heavy chain 9606
801 6B5M 2 L CIS43 Fab Light chain 9606
802 5AWN 1 H Heavy chain of 3BC176 Fab 9606
803 5AWN 2 L Light chain of 3BC176 Fab 9606
804 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
805 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
806 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
807 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
808 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
809 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
810 5DR5 2 L AbD09097 Fab light chain 9606
811 6MG5 1 A, B Light chain JTO 9606
812 2IH3 1 A FAB Heavy Chain 10090
813 2IH3 2 B FAB Light Chain 10090
814 4KQ3 1 L CNTO3186 light chain Fab 9606
815 4KQ3 2 H CNTO3186 heavy chain Fab 9606
816 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
817 6AQ7 3 L POM6 FAB light CHAIN 10090
818 4JFX 1 A, L Fab light chain 9606
819 4JFX 2 B, H Fab heavy chain 9606
820 3SGE 1 I, L Light Chain 10090
821 3SGE 2 H, J Heavy Chain 10090
822 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
823 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
824 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
825 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
826 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
827 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
828 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
829 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
830 5FHB 1 H Antibody 100 Fab heavy chain 9606
831 5FHB 2 L Antibody 100 Fab light chain 9606
832 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
833 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
834 1JGU 1 L Antibody Light Chain 10090
835 1JGU 2 H Antibody Heavy Chain 10090
836 4I77 1 H Lebrikizumab heavy chain Fab 9606
837 4I77 2 L Lebrikizumab light chain Fab 9606
838 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
839 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
840 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
841 4O4Y 2 H 2095-2 heavy chain 9986
842 5OBF 1 H fAb Heavy chain 10090
843 5OBF 2 L fAb Light chain 10090
844 6QNK 1 A, C FAB light chain 10090
845 6QNK 2 B, D FAB heavy chain 10090
846 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
847 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
848 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
849 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
850 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
851 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
852 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
853 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
854 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
855 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
856 5MHE 1 L Fab-fragment 10090
857 5MHE 2 H Fab-fragment 10090
858 5YFI 1 L Light chain of Fab fragment 10090
859 5YFI 2 H Heavy chain of Fab fragment 10090
860 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
861 4GLR 3 I, K anti-ptau light chain light chain 9031
862 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
863 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
864 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
865 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
866 4HJG 1 A Trastuzumab light chain 9606
867 4HJG 2 B Trastuzumab heavy chain 9606
868 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
869 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
870 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
871 5I30 1 L Fab PL-2 light chain 10090
872 5I30 2 H Fab PL-2 heavy chain 10090
873 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
874 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
875 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
876 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
877 6CT7 1 B, L BIIB054 Fab light chain 9606
878 6CT7 2 A, H BIIB054 Fab heavy chain 9606
879 3FN0 1 L Fab Z13e1 light chain 9606
880 3FN0 2 H Fab Z13e1 heavy chain 9606
881 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
882 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
883 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
884 4YHI 2 B, L aDabi-Fab2a light chain 9606
885 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
886 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
887 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
888 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
889 4OSU 1 H SM5-1 Fab Heavy Chain 9606
890 4OSU 2 L SM5-1 Fab Light Chain 9606
891 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
892 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
893 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
894 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
895 1T2Q 1 L Fab NNA7 Heavy Chain 10090
896 1T2Q 2 H Fab NNA7 Light Chain 10090
897 6ELJ 1 A, H fAB heavy chain 9606
898 6ELJ 2 B, L fAB light chain 9606
899 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
900 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
901 4MAU 1 L C2244 light chain SEE REMARK 999 10090
902 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
903 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
904 3LEX 2 B, L 11f10 Antibody Light Chain 10090
905 6B0W 1 L 1710 antibody, light chain 9606
906 6B0W 2 H 1710 antibody, heavy chain 9606
907 6DC7 1 L, M Fab light chain 10090
908 6DC7 2 H, I Fab heavy chain 10090
909 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
910 5VH4 2 B, L Infliximab Fab Light Chain 10090
911 6NOU 1 A scFv derived from ixekizumab 9606
912 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
913 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
914 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
915 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
916 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
917 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
918 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606